Advertisement

Topics

Bipolar I disorder drug from Otsuka, Lundbeck gets FDA nod

05:12 EDT 31 Jul 2017 | SmartBrief

The once-monthly, extended-release injectable Abilify Maintena, or aripiprazole, from Otsuka Pharmaceutical and H.  -More

Original Article: Bipolar I disorder drug from Otsuka, Lundbeck gets FDA nod

NEXT ARTICLE

More From BioPortfolio on "Bipolar I disorder drug from Otsuka, Lundbeck gets FDA nod"

Quick Search
Advertisement